Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 12,981 shares at $57.57 ($748K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $748k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.57 | 6,210 | $358K | 47.8% |
| 2 | $57.57 | 6,210 | $358K | 47.8% |
| 3 | $58.17 | 561 | $33K | 4.4% |
| Total | $57.60 avg | 12,981 | $748K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |